These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 25532538)

  • 1. Metformin: the past, presence, and future.
    Alušík Š; Paluch Z
    Minerva Med; 2015 Aug; 106(4):233-8. PubMed ID: 25532538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sitagliptin/metformin (Janumet) for type 2 diabetes.
    Med Lett Drugs Ther; 2007 Jun; 49(1262):45-7. PubMed ID: 17541377
    [No Abstract]   [Full Text] [Related]  

  • 3. Pioglitazone/metformin (Actoplus met).
    Med Lett Drugs Ther; 2006 Jan; 48(1227):9-11. PubMed ID: 16444136
    [No Abstract]   [Full Text] [Related]  

  • 4. Metformin: a multitasking medication.
    Bailey CJ
    Diab Vasc Dis Res; 2008 Sep; 5(3):156. PubMed ID: 18777487
    [No Abstract]   [Full Text] [Related]  

  • 5. Metformin therapy and clinical uses.
    Scarpello JH; Howlett HC
    Diab Vasc Dis Res; 2008 Sep; 5(3):157-67. PubMed ID: 18777488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination therapy with metformin plus vildagliptin in type 2 diabetes mellitus.
    Guarino E; Nigi L; Patti A; Fondelli C; Dotta F
    Expert Opin Pharmacother; 2012 Jun; 13(9):1377-84. PubMed ID: 22397507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Not Available].
    Steurer J
    Praxis (Bern 1994); 2016 Sep; 105(20):1221-1222. PubMed ID: 27705192
    [No Abstract]   [Full Text] [Related]  

  • 8. [New clinical data with metformin therapy in patients with diabetes mellitus].
    Jermendy G
    Orv Hetil; 2010 Dec; 151(49):2025-30. PubMed ID: 21106483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rosiglitazone maleate + metformin hydrochloride extend: review of an emerging compound.
    Cheng AY; Josse RG
    Expert Opin Investig Drugs; 2009 Sep; 18(9):1365-73. PubMed ID: 19642952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Oral antidiabetic therapy].
    Schneider S; Pazdzierny G; Klein HH
    Dtsch Med Wochenschr; 2006 Dec; 131 Suppl 8():S264-7. PubMed ID: 17139584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin: diamonds are forever.
    Papanas N; Maltezos E; Mikhailidis DP
    Expert Opin Pharmacother; 2009 Oct; 10(15):2395-7. PubMed ID: 19678795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Metformin. Mode of action and effect of monotherapy and combination therapy on glucose metabolism in type 2 diabetes].
    Christiansen AL; Madsbad S
    Ugeskr Laeger; 2002 Apr; 164(15):2025-8. PubMed ID: 11985000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Metformin and lactic acidosis--fact or fiction? A review of current data].
    Bläuer SC; Keller U
    Praxis (Bern 1994); 2003 Nov; 92(47):2008-10. PubMed ID: 14669502
    [No Abstract]   [Full Text] [Related]  

  • 14. Metformin--the gold standard in type 2 diabetes: what does the evidence tell us?
    Bosi E
    Diabetes Obes Metab; 2009 May; 11 Suppl 2():3-8. PubMed ID: 19385978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapeutic renaissance. Biguanides in type-2 diabetes: metformin].
    Neye H
    Pharm Unserer Zeit; 2002; 31(3):264-70. PubMed ID: 12071123
    [No Abstract]   [Full Text] [Related]  

  • 16. Metformin.
    Stumvoll M; Häring HU; Matthaei S
    Endocr Res; 2007; 32(1-2):39-57. PubMed ID: 18271504
    [No Abstract]   [Full Text] [Related]  

  • 17. Mortality risk with sulphonylureas compared to metformin.
    Holden SE; Currie CJ
    Diabetes Obes Metab; 2014 Oct; 16(10):885-90. PubMed ID: 24533964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Saxagliptin plus metformin combination in patients with type 2 diabetes and renal impairment.
    Scheen AJ
    Expert Opin Drug Metab Toxicol; 2012 Mar; 8(3):383-94. PubMed ID: 22313172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin and risk of cardiovascular disease.
    Turner RC; Holman RR
    Cardiology; 1999; 91(3):203-4. PubMed ID: 10516415
    [No Abstract]   [Full Text] [Related]  

  • 20. [Insulin sparing and metabolic control with metformin-insulin combination].
    Isnard F
    Journ Annu Diabetol Hotel Dieu; 1997; ():305-25. PubMed ID: 9296986
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.